Entera Bio(ENTX) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates JERUSALEM – August 9th, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), ("Entera" or the "Company") a leader in the development of orally delivered peptides and small therapeutic proteins, today reported financial results and key business updates for the quarter ended June 30, 2024. "We continue to deliver strong execution with key milestones achieved during the second quarter of 2024 across each of our N-Tab™ o ...